FUND II · LIMITED PARTNERS
Health care venture, rebuilt around the clinician-operator.
Clinician-led startups outperform. We back them with capital, a 200+ member clinician network for diligence and distribution, and the operating playbooks we've built as founders ourselves.
THESIS
Why clinician-led, why now, why us.
Why clinician-led wins
Clinician-founded companies are uniquely positioned to solve real problems in health care — they live in the workflow, understand the incentives, and can diligence each other's ideas with specificity outsiders can't match.
40% HIGHER MILESTONE SUCCESS (FUND I COHORT)
Why now
AI, regulatory modernization, and shifts in payor dynamics are creating a once-in-a-generation rebuild of health care infrastructure. The first generation of clinician-founders is finally entering its prime.
LARGEST HC VC DEPLOYMENT CYCLE IN 20 YEARS
Why Scrub
We're the only venture firm with a structured 200+ clinician-operator community actively doing diligence and distribution. Our founders get clinical signal in days, not months.
SOLE-SOURCE ACCESS TO 40+ SPECIALTIES
TRACK RECORD
Fund I by the numbers.
Portfolio companies
Exits & markups to date
Follow-on capital raised by portfolio
GENERAL PARTNERS
The team.
Two decades bridging the worlds of medicine, tech, and VC. Built and led industry-leading products used by tens of millions worldwide from 0-1, IPO, and the largest acquisition in health tech history. Former EVP at a $500M growth fund.
Practicing neurosurgeon with over 10 years driving the digital transformation of medicine at the nation’s largest integrated health system. Geisinger Chief Medical Officer for Strategy and Growth. Multiple-time medical device cofounder.
One of the most trusted voices and advisors in health technology. Owner of Second Opinion Media, author of The Storyteller’s Advantage. Former health tech lead at OMERS Ventures.
OUR PROCESS
From source to portfolio support.
01 / SOURCE
Source
Differentiated GP and clinician networks; regularly invited into oversubscribed rounds.
02 / DILIGENCE
Diligence
Two-week assessment with 30+ clinician experts offering specialty-specific signal.
03 / INVEST
Invest
Three-GP Investment Committee. When interest is high, SPVs run alongside the fund check.
04 / SUPPORT
Support
Recruiting, clinical advisory, GTM intros, and media amplification through our platforms.
FAQ
Common questions from LPs.
What's the fund size and structure?
Fund II targets $120M. Standard 10-year closed-end venture fund. Management fee and carry are disclosed in the materials — request them via the form below.
What's the strategy?
Pre-seed through Series A into clinician-founded or clinician-co-founded health care startups. We avoid Class III medical devices and pure therapeutics plays.
What's the minimum LP commitment?
$250K for most LPs; lower minimums available for active Collaborative members. Discussed case-by-case.
Do LPs get co-investment rights?
Yes. Active LPs get first look at SPVs on top-conviction deals.
How often do you report?
Quarterly financials, an annual LP meeting in person, and continuous portfolio narrative via the Differential newsletter.
Who's on the team?
Three GPs — Rebecca Mitchell (MD), Jonathan Slotkin (MD), Christina Farr — plus a venture partner focused on medical devices and a rotating cohort of venture fellows.
FUND II · LP APPLICATION
Request fund materials.
Share a few details and we'll follow up within 3 business days.